Cointime

Sharp Edge Labs

company

About

Sharp Edge Labs is engaged in the development of biosensors for cellular biology research and high-throughput screening.

  • 1 - 10

Highlights

Total Funding Amount
$600K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$600K
Industries
Biotechnology,Life Science,Medical Device
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Sharp Edge Labs, Inc. engages in developing biosensors for cellular biology research and high-throughput screening. The company’s products include targeted biosensors to the cellular biology research community. It offers its products based on the fluorogenic activating proteins that provide a detection method for cellular changes, which is amendable to high-throughput screening and follow-up.

The company was incorporated in 2011 and is based in Pittsburgh, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$600K
Sharp Edge Labs has raised a total of $600K in funding over 2 rounds. Their latest funding was raised on Aug 19, 2014 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 19, 2014 Series B $600K 1 Newlin Investment Company — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Sharp Edge Labs is funded by 1 investors. Newlin Investment Company are the most recent investors.
Investor Name Lead Investor Funding Round
Newlin Investment Company Yes Series B
Cointime
เนื้อหา
บริษัท